Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Pharmacia & Upjohn describes orally active anticonvulsants

April 7, 1997

FCE-29642A: a novel antiepileptic compound from Pharmacia & Upjohn

April 7, 1997

Calcium channel blockers disclosed by Warner-Lambert

April 7, 1997

Novo Nordisk claims metabotropic glutamate receptor antagonists

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Schering-Plough claims adenosine A2a antagonists

April 4, 1997

Novo Nordisk discloses metabotropic glutamate receptor antagonists

April 4, 1997

NeoTherapeutics seeks FDA clearance for AIT-082 clinical trials

April 3, 1997

Teva's Copaxone launched in U.S.

April 3, 1997

Glaxo Wellcome discloses prodrugs of known 5-HT1-like agonist

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...